I want to understand what in vivo brain imaging measures biologically. I relate imaging findings – in typical development and in psychiatric disorders – to maps of the brain's molecular and cellular makeup, from neurotransmitter systems to gene expression, and I develop open tools for this, such as NiSpace. My goal is a methodological gold standard for such spatial correlation analyses – validated methods, and the reference maps of known biology they depend on.
Lotter LD, Shafiei G, Larabi D, Koushik A, Dipasquale O, ..., Koenig J, Patil KR, Paquola C, Eickhoff SB, Dukart J (2026). bioRxiv.
Lotter LD, Dukart J (2025). Book chapter in: Neurobehavioral Individual Differences (Springer).
Lotter LD, Saberi A, Hansen JY, Misic B, Paquola C, ..., IMAGEN Consortium, Nees F, Banaschewski T, Eickhoff SB, Dukart J (2024). Nature Communications.
Lotter LD, Nehls S, Losse E, Dukart J, Chechko N (2024). Neuropsychopharmacology.
Lotter LD, Kohl SH, Gerloff C, Bell L, Niephaus A, Kruppa JA, Dukart J, Schulte-Rüther M, Reindl V, Konrad K (2023). Neuroscience & Biobehavioral Reviews.
Lotter LD, von Polier G, Offermann J, Buettgen K, Stanetzky L, Eickhoff SB, Konrad K, Seitz J*, & Dukart J* (2021). Biological Psychiatry - Cognitive Neuroscience and Neuroimaging.
Dukart J, Lotter LD, Paquola C, Eickhoff SB, Schilbach L (2026). Molecular Psychiatry.
Saberi A, Wischnewski KJ, Jung K, Lotter LD, ..., Popovych OV, Eickhoff SB, Valk SL (2025). Science Advances.
Corneille O, Havemann J, Henderson EL, Ijzerman H, Hussey I, Orban de Xivry J, Jussim L, Holmes NP, Pilacinski A, Beffara B, Carroll H, Outa NO, Lush P, Lotter LD (2023). eLife.
*shared authorships
Portrait @ Nikolaus Brade
I am a physician scientist working at the intersection of neuroimaging and the molecular and cellular biology of the human brain. I trained in medicine at RWTH Aachen University and obtained my doctorate (Dr. med.) with a thesis on resting-state functional MRI in anorexia nervosa.
I am a research associate at the Institute of Neuroscience and Medicine: Brain and Behaviour (INM-7), Forschungszentrum Jülich, and the Institute of Systems Neuroscience, University Hospital Düsseldorf, where I work in Jürgen Dukart's Biomarker Development Group. Alongside, I am completing an additional PhD in the Clinician Scientist Program of the Max Planck School of Cognition.